MAOA and Alzheimer disease: We unveiled Rebamipide’s significant affinity and interactions with AD-related proteins, such as NR1 ligand binding core, Human Beta Secretase, Human Monoamine Oxidase A, and Human Acetylcholinesterase, through meticulous molecular interaction analyses.